Social and Behavioral Aspects of Pharmaceutical CareCRC Press, 12/07/1996 - 835 من الصفحات Social and Behavioral Aspects of Pharmaceutical Care takes known social and behavioral science principles and applies them to pharmacy practice. This allows readers who are training to deliver or already delivering pharmaceutical care to enhance their communication, counseling, and patient education skills. While working through this superb text, students and practitioners will develop optimal skills as problemsolvers, therapeutic consultants, patient educators, and counselors as they learn how to enhance patient compliance, negate stigma, and help patients become more comfortable with their medical situations. The instructor?s manual that comes with the text is filled with exercises that highlight the most important aspects of each chapter and engages readers in the content of each chapter.Readers who approach this text with a real desire to better understand how behavior links to the complexities of an individual?s or social group?s actions and deeds will find it exhilarating reading as they gain a better understanding of and appreciation for pharmaceutical care and its behavioral underpinnings. Also, instead of offering only a few definitive answers, Social and Behavioral Aspects of Pharmaceutical Care contains extensive descriptions of phenomena known to be true but which are all subject to change when new variables are introduced. This helps readers become more aware of and comfortable with the “gray” areas of pharmacy.Authors in Social and Behavioral Aspects of Pharmaceutical Care take pieces of the complex web of pharmaceutical care, describe known microcosmic components of such care, and then relate the pieces back to the integrity of the web. Readers will find that the behavior of the patient, the prescriber, the systems that allow for these interactions, and, ultimately, the outcomes of medication use are in fact, not as simple as they may appear. Readers learn to deal with these complexities by improving their interactive skills in these areas:
|
من داخل الكتاب
النتائج 1-5 من 80
الصفحة
عذرًا، محتوى هذه الصفحة مقيَّد.
عذرًا، محتوى هذه الصفحة مقيَّد.
الصفحة 14
عذرًا، محتوى هذه الصفحة مقيَّد.
عذرًا، محتوى هذه الصفحة مقيَّد.
الصفحة 17
عذرًا، محتوى هذه الصفحة مقيَّد.
عذرًا، محتوى هذه الصفحة مقيَّد.
الصفحة 22
عذرًا، محتوى هذه الصفحة مقيَّد.
عذرًا، محتوى هذه الصفحة مقيَّد.
الصفحة 78
عذرًا، محتوى هذه الصفحة مقيَّد.
عذرًا، محتوى هذه الصفحة مقيَّد.
المحتوى
CONCEPTS OF HEALTH AND ILLNESS | 3 |
Illness Sickness and Disease | 21 |
PATIENT RESPONSES TO SYMPTOMS | 41 |
Empirical Data | 49 |
Does | 50 |
Discussion | 60 |
Chronic and Acute Symptoms | 66 |
Symptoms and Change with Chronic Disease | 74 |
Types of Economic Analyses | 392 |
Critical Evaluation of the Health Economic Literature | 398 |
Jeffrey A Johnson | 403 |
Satisfaction with Pharmacy Services | 435 |
Children and Medicines | 449 |
Childrens MedicineRelated Beliefs and Behaviors | 456 |
Helping Children Learn About Medicines | 464 |
Adolescents and College Students | 473 |
Some Limitations of This Approach | 80 |
What Is Image? | 86 |
Strategies for Image Improvement | 94 |
Mary ZwygartStauffacher | 99 |
The Adaptation of Medicine | 105 |
The Practice of Dentistry | 111 |
Unorthodox Healing Systems | 123 |
Hydrotherapy | 131 |
Wave and Radiation | 137 |
SelfExercise | 143 |
CHOOSING A THERAPEUTIC AGENT | 149 |
Methods Used to Influence Prescribing | 159 |
Conclusions | 176 |
Pharmacists Performance in Drug Product | 185 |
Therapeutic Interchange | 197 |
Conclusions | 207 |
Interprofessional Relations in Drug Therapy | 213 |
Barriers to Interprofessional Relations | 222 |
Patient Prescriber Pharmacist | 230 |
Conclusion | 245 |
Consumer Behavior | 254 |
Prescription Medications and Consumer Goods | 261 |
Prescription Medication Use | 271 |
Providing Pharmaceutical Care to Medication Consumers | 285 |
MEDICATIONTAKING BEHAVIOR | 295 |
The Case of Minor Tranquilizers | 304 |
Prescribing Dilemmas | 314 |
Predicting and Detecting Noncompliance | 323 |
Explaining and Changing Noncompliant | 351 |
Changing Noncompliant Behavior | 362 |
Compliance Enhancement in Tomorrows World | 370 |
OUTCOMES OF PHARMACEUTICAL CARE | 379 |
Economic Outcomes | 385 |
Ambulatory Elderly | 515 |
General Health Concerns | 522 |
Conclusion and Commentary | 531 |
Social | 537 |
An Overview | 544 |
Conclusion | 555 |
A Conceptual Basis of Care | 563 |
Conclusion | 579 |
Pharmaceutical Care of Terminally | 585 |
2 | 604 |
Mental Disorders | 611 |
Selected Psychosocial Principles of Mental Disorder | 619 |
Principles of Longitudinal Monitoring | 627 |
Cultural Issues in the Practice of Pharmacy | 635 |
Culturally Sensitive Practices | 641 |
Public Policy | 651 |
The Demand for and Supply of Public Policy | 657 |
Approaches to Improving Health Status | 659 |
Public Input and Participatory Democracy | 669 |
The Rebirth of Cognitive Services | 675 |
Gaining Reimbursement for Cognitive Services | 691 |
Conclusion | 706 |
Recent Developments in Behavioral Medicine | 715 |
What Are Behavioral Medicines Interventions? | 725 |
What Does This Mean for a Pharmacist? | 731 |
Expectations Education and Technology | 737 |
Technology | 749 |
Pharmacy Education | 757 |
Conclusion | 764 |
Ethical Concerns in Drug Research | 773 |
Epilogue | 801 |
809 | |
طبعات أخرى - عرض جميع المقتطفات
عبارات ومصطلحات مألوفة
activities administration adolescents adverse drug reactions African Americans alternative analysis antibiotic assessment associated attitudes benefits beta blocker bioequivalence Bootman chronic illness cists Clin clinical clinical pharmacists community pharmacists consumer cost-minimization analysis costs decision developed digoxin disease dispensing doctor dose drug information drug product selection drug therapy economic elderly evaluation example factors formulary health behavior Health Belief Model health care system health professionals Hosp Pharm hospital hypertension identified important improve increased individual influence prescribing interactions interventions involved issues macists measure medication medicine ment monitoring noncompliance nonprescription nursing organization outcomes patient satisfaction perceived person perspective phar pharmaceutical pharmacoeconomic pharmacy practice pharmacy services physician pliance population potential practitioners problems programs regimen relationship reported response result role self-medication self-treatment sick sick role side effects situation Soc Sci social specific symptoms therapeutic interchange tion treatment
مقاطع مشهورة
الصفحة 797 - In any research on human beings, each potential subject must be adequately informed of the aims, methods, anticipated benefits and potential hazards of the study and the discomfort it may entail. He or she should be informed that he or she is at liberty to abstain from participation in the study and that he or she is free to withdraw his or her consent to participation at any time.
الصفحة 797 - In that case the informed consent should be obtained by a doctor who is not engaged in the investigation and who is completely independent of this official relationship. 11. In case of legal incompetence, informed consent should be obtained from the legal guardian in accordance with national legislation. Where physical or mental incapacity makes it impossible to obtain informed consent, or when the subject is a minor, permission from the responsible relative replaces that...
الصفحة 797 - When obtaining informed consent for the research project the physician should be particularly cautious if the subject is in a dependent relationship to him or her or may consent under duress.
الصفحة 797 - The research protocol should always contain a statement of the ethical considerations involved and should indicate that the principles enunciated in the present Declaration are complied with.